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Abstract
IMPORTANCE Delirium is common among older emergency department (ED) patients, is associated
with high morbidity and mortality, and frequently goes unrecognized. Anecdotal evidence has
described atypical presentations of coronavirus disease 2019 (COVID-19) in older adults; however,
the frequency of and outcomes associated with delirium in older ED patients with COVID-19 infection
have not been well described.
OBJECTIVE To determine how frequently older adults with COVID-19 present to the ED with
delirium and their associated hospital outcomes.
DESIGN, SETTING, AND PARTICIPANTS This multicenter cohort study was conducted at 7 sites in
the US. Participants included consecutive older adults with COVID-19 presenting to the ED on or after
March 13, 2020.
EXPOSURE COVID-19 was diagnosed by positive nasal swab for severe acute respiratory syndrome
coronavirus 2 (99% of cases) or classic radiological findings (1% of cases).
MAIN OUTCOMES AND MEASURES The primary outcome was delirium as identified from the
medical record according to a validated record review approach.
RESULTS A total of 817 older patients with COVID-19 were included, of whom 386 (47%) were male,
493 (62%) were White, 215 (27%) were Black, and 54 (7%) were Hispanic or Latinx. The mean (SD)
age of patients was 77.7 (8.2) years. Of included patients, 226 (28%) had delirium at presentation,
and delirium was the sixth most common of all presenting symptoms and signs. Among the patients
with delirium, 37 (16%) had delirium as a primary symptom and 84 (37%) had no typical COVID-19
symptoms or signs, such as fever or shortness of breath. Factors associated with delirium were age
older than 75 years (adjusted relative risk [aRR], 1.51; 95% CI, 1.17-1.95), living in a nursing home or
assisted living (aRR, 1.23; 95% CI, 0.98-1.55), prior use of psychoactive medication (aRR, 1.42; 95%
CI, 1.11-1.81), vision impairment (aRR, 1.98; 95% CI, 1.54-2.54), hearing impairment (aRR, 1.10; 95% CI
0.78-1.55), stroke (aRR, 1.47; 95% CI, 1.15-1.88), and Parkinson disease (aRR, 1.88; 95% CI, 1.30-2.58).
Delirium was associated with intensive care unit stay (aRR, 1.67; 95% CI, 1.30-2.15) and death
(aRR, 1.24; 95% CI, 1.00-1.55).
CONCLUSIONS AND RELEVANCE In this cohort study of 817 older adults with COVID-19 presenting
to US emergency departments, delirium was common and often was seen without other typical
symptoms or signs. In addition, delirium was associated with poor hospital outcomes and death.
(continued)
Key Points
Question How frequently do older
adults (aged 65 years) with
coronavirus disease 2019 (COVID-19)
present to the emergency department
(ED) with delirium?
Findings In this cohort study of 817
older ED patients with COVID-19, 28%
had delirium at presentation, and
delirium was the sixth most common of
all presenting symptoms and signs.
Among delirious patients, 16%
presented with delirium as a primary
symptom and 37% had no typical
COVID-19 symptoms or signs, such as
cough or fever.
Meaning These findings suggest that
older adults with COVID-19 commonly
present to the ED with delirium and that
delirium should be considered an
important presenting symptom of
COVID-19.
Author affiliations and article information are
listed at the end of this article.
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Abstract (continued)
These findings suggest the clinical importance of including delirium on checklists of presenting signs
and symptoms of COVID-19 that guide screening, testing, and evaluation.
JAMA Network Open. 2020;3(11):e2029540. doi:10.1001/jamanetworkopen.2020.29540
Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes
coronavirus disease 2019 (COVID-19), was declared a pandemic on March 11, 2020, by the World
Health Organization1 and a national emergency in the US on March 13, 2020.2 As of September 14,
2020, there were 29 114 477 confirmed cases of COVID-19 with 925 596 fatalities worldwide.3
Although SARS-CoV-2 poses a risk at all ages, adults aged 65 years and older are at greatest risk of
severe disease, hospitalization, intensive care use, and death.4 Persons older than 65 years comprise
16% of the US population5 yet have accounted for more than 80% of deaths in the US.6
Beyond COVID-19, delirium is known to be a common presenting symptom for older adults with
severe disease in the emergency department (ED) but goes undetected in two-thirds of cases.7,8
Delirium is an acute state of confusion, characterized by altered level of consciousness,
disorientation, inattention, and other cognitive disturbances, that commonly affects older persons
and is associated with adverse outcomes, including prolonged hospitalization and death.9,10 In
non–COVID-19 illness, delirium may be the earliest, or only, sign of an infection.11 In older adults
infected by SARS-CoV-2, anecdotal evidence and case series have described atypical presentations—
namely, patients presenting without the typical signs or symptoms of an illness or with nonspecific
signs and symptoms.12 For example, older persons can present with delirium in the absence of typical
signs and symptoms of COVID-19, such as fever or cough.13-17 Early COVID-19 studies have estimated
rates of delirium at 25% to 33% in hospitalized patients18,19 and 65% in intensive care unit (ICU)
patients.20 In one study,21 among 113 patients with COVID-19 who died, 22% presented with altered
level of consciousness, compared with 1% of those who recovered. The frequency of and outcomes
associated with delirium among older adults with COVID-19 infection in the ED setting, however,
have not been well described, to our knowledge. This information is critical to ensure early
recognition of COVID-19 by frontline clinicians. The primary objective of this descriptive study was to
determine the frequency of delirium as a presenting symptom of COVID-19 infection among older
adults in the ED.
Methods
Overall Study Description
We conducted a multicenter cohort study evaluating consecutive older adults (aged 65 years)
presenting to the ED and diagnosed with COVID-19 infection. Seven ED study sites were selected
from across the US and included EDs in the Northeast (Boston, Massachusetts; Portland, Maine; and
New Haven, Connecticut), Midwest (Livonia, Michigan), and South (Chapel Hill and Hillsborough,
North Carolina). Each site reviewed and extracted deidentified data for consecutive older patients
presenting to the ED on or after March 13, 2020 (the date COVID-19 was declared a national
emergency in the US), and diagnosed with COVID-19, and continued reviewing consecutive medical
records until either all medical records for COVID-19–positive patients were reviewed or at least 30
patients with delirium were included from that site. The period for which patients were enrolled
varied by site (range, 3-11 weeks) because of variations in COVID-19 prevalence and ED
patient volume.
Each study site secured relevant study approvals with waiver of informed consent, because the
data were deidentified, or a determination of exemption from review by its institutional review
JAMA Network Open | Emergency Medicine Delirium in Older Patients With COVID-19 Presenting to the Emergency Department
JAMA Network Open. 2020;3(11):e2029540. doi:10.1001/jamanetworkopen.2020.29540 (Reprinted) November 19, 2020 2/12
Downloaded From: https://jamanetwork.com/ by a University of Massachusetts User  on 11/30/2020
board. The study was deemed as exempt by the institutional review board at Hebrew SeniorLife, the
study coordinating center. This study follows Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) reporting guideline.
Study Population
We enrolled consecutive patients aged 65 years or older presenting to the ED and diagnosed with
active COVID-19 infection, which was defined by either positive nasal swab polymerase chain
reaction (PCR) test for SARS-CoV-2 (99% of cases) or chest radiograph or computed tomography
demonstrating classic COVID-19 appearance and distribution of ground-glass opacities (1% of cases).
We allowed the inclusion of high-probability radiographic diagnosis of COVID-19 because of national
shortages in PCR tests; all but 4 of these cases were confirmed by positive SARS-CoV-2 test results.
Approach
Data were extracted using a standardized data abstraction form. For consistency in data abstraction
across locations, site investigators attended training sessions led by the principal investigator (S.K.I.),
and centralized training documents were distributed. Data abstraction was performed by site
investigators, who were experienced clinicians, or trained research assistants under close
supervision.
The primary outcome was the presence of delirium at presentation to the ED. Delirium was
identified through a reliable and widely used medical record review approach, with a sensitivity of
74%, specificity of 83%, likelihood ratio of 4.4, overall agreement of 82% (κ = 0.41) for delirium
diagnoses, as validated against the Confusion Assessment Method,22 and high interrater reliability
(κ = 1.0).23 This method has been used in many prior studies.19,23-27 The approach involves a detailed
review of all physician, nursing, and other notes for presence of keywords related to delirium and
evidence of acute change from baseline. Diagnosis codes for delirium are noted, but the rating is not
based on these alone. All potential delirium symptoms and signs were recorded, and any uncertain
cases were adjudicated by at least 2 clinical experts. Some sites routinely used delirium screening
tools, which aided in delirium detection. In addition to the presence of delirium and how it was
identified, we recorded delirium duration before presentation.
A checklist of the presence of any of 25 symptoms and signs associated with COVID-19
infection, derived from the Centers for Disease Control and Prevention (CDC), World Health
Organization case report checklists, and epidemiological studies, was used to record specific
presenting symptoms and signs for each patient. Other data collected included the specific method
of COVID-19 diagnosis, patient demographic characteristics (age, sex, race/ethnicity, English-
language fluency, education, and living situation), preadmission delirium risk factors (prior use of
psychoactive medications, alcohol, smoking, and any of 14 major comorbid illnesses documented in
the medical record, including cognitive impairment or dementia, stroke, Parkinson disease, chronic
kidney disease, and sensory impairment), and clinical outcomes, including hospitalization rates, ICU
stay, use of mechanical ventilation, hospital length of stay, hospital disposition, and mortality. Data
were entered for electronic data capture via SurveyGizmo Premium software (Alchemer). No
identifying data were collected, and age older than 90 years was recorded as greater than or equal
to 90 years. All uploaded data were blinded to specific site location.
Statistical Analysis
For baseline characteristics and symptoms at presentation, standard descriptive statistics were
reported. To analyze factors associated with risk of delirium, we used generalized linear models
assuming a Poisson distribution with a log-link function to estimate the relative risk (RR) of delirium
with robust SEs. We used the generalized linear models approach because it provides stable
estimates even with small sample sizes and direct estimation of RRs.28 After examining distributions,
each risk factor was first examined in an unadjusted model, and then all significant risk factors were
examined together in a multivariable model. Because of a high rate of missing data, education was
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removed from the multivariable model. Variables that demonstrated high multicollinearity were
removed, yielding the final multivariable risk factor model. To analyze outcomes associated with
delirium, the RR of outcome events in the presence (vs absence) of delirium was estimated in both
unadjusted and multivariable generalized linear models, adjusted for age older than 75 years, the
presence of 4 or more comorbid conditions, nursing home or assisted living residency, and use of
psychoactive medications. Missing data, not reported in the medical record, were present for only 4
variables: education (627 patients [77%]), race/ethnicity (30 patients [4%]), English fluency (16
patients [2%]), and hospital length of stay (1 patient [<1%]). The small numbers of patients with
missing data were excluded from the relevant risk factor analyses (eg, for race and English fluency),
and 1 person with missing data was excluded from the length of stay outcome analysis. All statistical
analyses were conducted with Stata statistical software version 15 (StataCorp). Significance testing
for all analyses was 2-sided with a type I error of .05.
Results
A total of 817 patients were examined, of whom 386 (47%) were male, 493 (62%) were White, 215
(27%) were Black, and 54 (7%) were Hispanic or Latinx (Table 1). The mean (SD) age of study
participants was 77.7 (8.2) years, and 213 (26%) resided in a skilled nursing facility.
Table 2 shows the most common COVID-19 symptoms and signs reported on presentation to
the ED, including fever (459 patients [56%]), shortness of breath (420 patients [51%]), cough (412
patients [50%]), hypoxia (324 patients [40%]), and weakness (241 patients [30%]). A total of 226
patients (28%) had delirium at presentation, and delirium was the sixth most common of all
presenting symptoms and signs. Most cases of delirium were identified either from physician (178
patients [79%]) or nursing (133 patients [59%]) assessments. Of the cases of delirium identified
through the review of the medical records, only 22% of diagnoses (for 50 patients) were
documented using a delirium assessment tool; however, this is likely an underestimate because
clinicians may have used a tool without specific medical record documentation. Of patients with
delirium, 37 (16%) had delirium as a primary presenting complaint. Importantly, among patients with
delirium, 84 (37%) had no fever or shortness of breath. Common symptoms of delirium recorded in
the medical record (Table 2) included impaired consciousness (122 patients [54%]), disorientation
(96 patients [43%]), hypoactive delirium symptoms (45 patients [20%]), and agitation or
hyperactive delirium symptoms (35 patients [16%]). Of all patients who had delirium, 112 (50%)
Table 1. Characteristics of Older Emergency Department Patients
With Coronavirus Disease 2019
Characteristic
Patients, No. (%)
(N = 817)
Age, mean (SD), y 77.7 (8.2)
Male 386 (47)
Race/ethnicitya
White 493 (62)
Black 215 (27)
Hispanic or Latinx 54 (7)
Asian 12 (2)
Multiracial 19 (2)
Not reported 24 (3)
Education less than high school 34 (18)
English, nonfluent 111 (14)
Living in nursing home 213 (26)
Living in assisted living 84 (10)
a Multiple categories were allowed, so the total percentage exceeds 100%.
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presented to the ED within 2 days of onset of delirium and the vast majority (213 patients [94%])
were hospitalized.
Table 3 presents factors potentially associated with risk of delirium. Significant prebaseline risk
factors included age older than 75 years (459 patients [56%]), prior psychoactive medications (464
patients [57%]), and living in a nursing home or assisted living (297 patients [36%]). Preexisting
comorbidities associated with increased risk for delirium included vision impairment (59 patients
Table 2. Symptoms and Signs at Emergency Department Presentation
in Older Adults With Coronavirus Disease 2019
Symptoms
Patients, No.
(%) (N = 817)
Symptom at presentation
Fever 459 (56)
Shortness of breath 420 (51)
Cough 412 (50)
Hypoxia (oxygen saturation <90%) 324 (40)
Weakness 241 (30)
Delirium 226 (28)
Fatigue 210 (26)
Diarrhea 130 (16)
Anorexia 122 (15)
Myalgias 99 (12)
Fall 91 (11)
Dizziness, fainting 70 (9)
Abdominal pain 66 (8)
Acute respiratory failure 54 (7)
Headache 51 (6)
Chest pain 50 (6)
Sore throat 48 (6)
Other symptomsa 106 (13)
Delirium at presentation (n = 226)
Delirium as main or primary presenting symptom 37 (16)
Delirium present without fever or shortness of breath 84 (37)
Approach for delirium identification
Delirium assessment tool 50 (22)
Physician assessment 178 (79)
Nursing assessment 133 (59)
Delirium symptoms present
Impaired consciousness 122 (54)
Disorientation 96 (43)
Inattention 71 (31)
Disorganized thinking 59 (26)
Hypoactive delirium 45 (20)
Agitation or hyperactive delirium 35 (16)
Memory loss 18 (8)
Hallucinations 7 (3)
Duration of delirium symptoms before emergency
department presentation
<2 d 112 (50)
Between 2 d to 1 wk 60 (27)
>1 wk 8 (4)
Not reported 36 (16)
a Other symptoms (each reported in <5% of cases) included injury, dehydration,
gait disturbance, acute impairment in taste, smell, or vision, acute
cerebrovascular event, microembolic phenomenon, and seizure.
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[7%]), hearing impairment (54 patients [7%]), cognitive impairment or dementia (248 patients
[30%]), history of stroke or cerebrovascular accident (107 patients [13%]), Parkinson disease (23
patients [3%]), and mental health conditions (227 patients [28%]). The presence of 4 or more of the
14 chronic comorbidities was associated with a significant 1.58-fold increased risk for delirium (RR,
1.58; 95% CI, 1.23-2.04). There was no significant difference in delirium rates by sex or race/ethnicity groups.
The final multivariable risk factor model consisted of age older than 75 (adjusted RR [aRR], 1.51;
95% CI, 1.17-1.95), nursing home or assisted living facility residence (aRR, 1.23; 95% CI, 0.98-1.55),
prior use of psychoactive medications (aRR, 1.42; 95% CI, 1.11-1.81), vision impairment (aRR, 1.98;
95% CI, 1.54-2.54), hearing impairment (aRR, 1.10; 95% CI 0.78-1.55), stroke (aRR, 1.47; 95% CI,
1.15-1.88), and Parkinson disease (aRR, 1.88; 95% CI, 1.30-2.58) (Table 4). Dementia and mental
health conditions were removed from the final model because of multicollinearity. Use of
psychoactive medications before presentation was present in 57% of the cohort (464 patients), and
included antidepressants (237 patients [29%]), sleeping medications (142 patients [17%]),
anticonvulsants (91 patients [11%]), opioids (89 patients [11%]), antipsychotics (79 patients [10%]),
and other medication classes (73 patients each [<10% each]). Patients may have been taking
multiple medication classes.
Table 3. Risk Factors and Correlates of Delirium in Older Emergency Department Patients
With Coronavirus Disease 2019
Risk factor
Risk factor
prevalence,
patients, No. (%)
(N = 817)
Patients with delirium, No./total (%)
RR (95% CI)Risk factor present Risk factor absent
Risk factors (before baseline)a
Age >75 y 459 (56) 157/459 (34) 69/358 (19) 1.77 (1.39-2.27)
Male 386 (47) 103/386 (27) 123/431 (29) 0.94 (0.75-1.17)
Black 215 (27) 58/215 (27) 164/578 (28) 0.95 (0.74-1.23)
Hispanic or Latinx 54 (7) 11/54 (20) 211/739 (29) 0.71 (0.42-1.22)
Nonwhite race 300 (38) 79/300 (26) 143/493 (29) 0.91 (0.72-1.15)
English, nonfluent 111 (14) 29/111 (26) 193/690 (28) 0.93 (0.67-1.31)
Living in nursing home 213 (26) 72/213 (34) 154/604 (26) 1.33 (1.05-1.67)
Living in nursing home or
assisted living
297 (36) 104/297 (35) 122/520 (24) 1.49 (1.20-1.86)
Heavy alcohol use 20 (2) 4/20 (20) 222/797 (28) 0.72 (0.30-1.74)
Active smoker 16 (2) 5/16 (31) 221/801 (28) 1.13 (0.54-2.36)
Prior psychoactive medication
use
464 (57) 155/464 (33) 71/353 (20) 1.66 (1.30-2.12)
Chronic conditions (comorbidities)
≥4 Chronic conditions 119 (15) 48/119 (40) 178/698 (26) 1.58 (1.23-2.04)
Vision impairment 59 (7) 36/59 (61) 190/758 (25) 2.43 (1.92-3.09)
Hearing impairment 54 (7) 23/54 (43) 203/763 (27) 1.60 (1.15-2.23)
Cognitive impairment or
dementia
248 (30) 95/248 (38) 131/569 (23) 1.66 (1.34-2.07)
Stroke or cerebrovascular
accident
107 (13) 46/107 (43) 180/710 (25) 1.70 (1.32-2.18)
Parkinson disease 23 (3) 14/23 (61) 212/794 (27) 2.28 (1.61-3.23)
Chronic pulmonary disease 221 (27) 53/221 (24) 173/596 (29) 0.83 (0.63-1.08)
Diabetes 312 (38) 90/312 (29) 136/505 (27) 1.07 (0.85-1.34)
Obesity (body mass index ≥35)b 67 (8) 21/67 (31) 205/750 (27) 1.15 (0.79-1.67)
Active cancer 37 (5) 10/37 (27) 216/780 (28) 0.98 (0.57-1.68)
Chronic kidney disease 179 (22) 51/179 (29) 175/638 (27) 1.04 (0.80-1.35)
Requiring hemodialysis 38 (5) 8/38 (21) 218/779 (28) 0.75 (0.40-1.41)
Chronic liver disease 23 (3) 8/23 (35) 218/794 (28) 1.27 (0.72-2.24)
Immunosuppressive conditions 69 (8) 14/69 (20) 212/748 (28) 0.72 (0.44-1.16)
Mental health conditions 227 (28) 76/227 (34) 150/590 (25) 1.32 (1.05-1.66)
Abbreviation: RR, relative risk.
a Data are missing on race variables for 3% of cases
and on English fluency for 2% of cases.
b Body mass index is calculated as weight in kilograms
divided by height in meters squared.
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Clinical outcomes in this COVID-19 cohort are presented in Table 5. Outcomes significantly
associated with delirium after adjustment included hospital admission (aRR, 1.06; 95% CI, 1.02-1.10),
any ICU stay (aRR, 1.67; 95% CI, 1.30-2.15), discharge to a rehabilitation facility (aRR, 1.55, 95% CI,
1.07-2.26), and death (aRR, 1.24; 95% CI, 1.00-1.55).
Discussion
In this multicenter retrospective cohort study, 28% of 817 older patients with COVID-19 infection had
delirium on arrival to the ED, and delirium was the sixth most common presenting symptom or sign
overall. Among patients with delirium, delirium was the main presenting symptom in 16%.
Importantly, 37% of patients with delirium did not have typical COVID-19 symptoms of fever or
shortness of breath. Factors associated with risk of delirium included older age, prior psychoactive
medication use, assisted living or skilled nursing facility residence, vision or hearing impairment,
stroke, and Parkinson disease. Delirium at presentation was significantly associated with increased
risk for poor hospital outcomes, including ICU stay, discharge to a rehabilitation facility, and death.
The rate of delirium in this cohort is much higher than typically reported in ED studies before
COVID-19, which ranged from 7% to 20%,29 although the factors associated with risk of delirium are
similar to those identified in ED and inpatient research before COVID-19.7,30,31 Mounting evidence
supports the high occurrence of delirium and other neuropsychiatric manifestations with COVID-19,
with previously reported rates of 22% to 33% among hospitalized patients.19,21 In another medical
Table 4. Factors Associated With Risk of Delirium in Older Emergency Department Patients
With Coronavirus Disease 2019
Risk factor
Patients, No. (%)
(N = 817) Adjusted RR (95% CI)
Age >75 y 459 (56) 1.51 (1.17-1.95)
Living in nursing home or assisted living 297 (36) 1.23 (0.98-1.55)
Prior psychoactive medications 464 (57) 1.42 (1.11-1.81)
Vision impairment 59 (7) 1.98 (1.54-2.54)
Hearing impairment 54 (7) 1.10 (0.78-1.55)
Stroke or cerebrovascular accident 107 (13) 1.47 (1.15-1.88)
Parkinson disease 23 (3) 1.88 (1.30-2.58)
Abbreviation: RR, relative risk.
Table 5. Outcomes Associated With Delirium in Older Emergency Department Patients
With Coronavirus Disease 2019
Outcome
Outcome rate, patients, No./total (%) RR (95% CI)
Overall
(N = 817)
Patients with
delirium
(n = 226)
Patients
without
delirium
(n = 591) Crude Adjusteda
Admitted to hospital from
emergency department
737 (90) 213 (94) 524 (89) 1.06 (1.02-1.11) 1.06 (1.02-1.10)
Any intensive care unit
stayb
191/737 (26) 72/213 (34) 119/524 (23) 1.49 (1.16-1.90) 1.67 (1.30-2.15)
Received mechanical
ventilationc
126/191 (66) 42/72 (58) 84/119 (71) 0.83 (0.66 – 1.04) 0.89 (0.71-1.12)
Median hospital length of
stay >8 db
353/737 (48) 109/213 (51) 244/524 (47) 1.10 (0.93-1.29) 1.14 (0.97-1.35)
Discharged to
Home 195 (24) 35 (15) 160 (27) 0.57 (0.41-0.80) 0.77 (0.56-1.07)
Assisted living 21 (3) 8 (4) 13 (2) 1.61 (0.68-3.83) 1.21 (0.49-3.00)
Rehabilitation 111 (14) 41 (18) 70 (12) 1.53 (1.08-2.18) 1.55 (1.07-2.26)
Nursing home 116 (14) 31 (14) 85 (14) 0.95 (0.65-1.40) 0.83 (0.57-1.20)
Hospice 15 (2) 2 (1) 13 (2) 0.40 (0.09-1.77) 0.37 (0.08-1.78)
In-hospital death 238 (29) 84 (37) 154 (26) 1.43 (1.15-1.77) 1.24 (1.00-1.55)
Abbreviation: RR, relative risk.
a Adjusted for age older than 75 years, the presence of
4 or more comorbid conditions, living in nursing
home or assisted living, and prior psychoactive
medications.
b The sample for any intensive care unit stay and
hospital length of stay more than 8 days is 737
patients.
c The sample for receiving mechanical ventilation is 191
patients, the same number of patients requiring
intensive care unit care.
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record–based study, delirium was reported to be present in 12% of ED patients aged 50 years and
older with COVID-19.19 Factors potentially contributing to the higher rate of delirium in our study
include use of a structured delirium assessment tool at some sites and higher prevalence of comorbid
conditions in and older age of our study population. In our cohort, 30% of patients had a prior
diagnosis of cognitive impairment or dementia and 13% had a prior history of stroke, compared with
4% and 7%, respectively, in a previous study,19 and those groups are at high risk for delirium.7,31 The
racial and ethnic diversity of our cohort may have contributed to higher rates of delirium because
non-White patients hospitalized with COVID-19 may present with higher severity of disease in the
US.32 It is also possible that the patients may have presented to the ED at a later stage of COVID-19
because of family or clinicians not recognizing delirium as an important symptom, or because of
delays in assessment either from fear of exposure to COVID-19 or difficulty accessing medical care.
Commonly cited typical COVID-19 symptoms include fever, cough, shortness of breath, and
difficulty breathing.33 Fever has been reported to be present in 80% of patients with COVID-19,33 but
it was present in only 56% of our patients. The absence of typical symptoms or signs is potentially
attributable to physiological changes associated with aging. Older adults have a lower basal
temperature and an impaired ability to mount a febrile response in the setting of acute infection.34
Among patients with delirium in our study, approximately one-third (37%) lacked the typical
symptoms and signs of COVID-19 (ie, fever or shortness of breath). Our study demonstrates that
clinicians must include COVID-19 in the differential diagnosis of delirium among older adults,
regardless of whether they have other symptoms of COVID-19 infection. This is important to avoid
missing diagnoses altogether and to better identify severe cases of COVID-19 at high risk for poor
outcomes and death. Furthermore, the data from this multicenter study strongly support an
immediate revision in CDC guidance on symptom profiles for COVID-19 to include delirium as an
important COVID-19–related symptom. Current CDC guidance lists new confusion as an emergency
warning sign only, not as a presenting symptom in COVID-19. Many centers use the CDC guidance to
prioritize screening, testing, and evaluation of presenting patients. By continuing to exclude delirium
as a known presenting symptom of COVID-19, many cases will be missed or diagnoses delayed, as is
already happening on a wide scale, particularly in older adults.35,36
Delirium was associated with adverse outcomes, including ICU stay and death. Thus, delirium
can serve as an important marker to identify patients at high risk for poor outcomes. Although our
study was unique and innovative in documenting the atypical presentation of COVID-19 in our older
adult population, our findings also serve to confirm a recent study19 that similarly demonstrated that
inpatient delirium among middle-aged and older adults with COVID-19 is associated with ICU stay
(adjusted odds ratio, 3.32), mechanical ventilation (adjusted odds ratio, 1.99), and in-hospital death
(adjusted odds ratio, 1.75).
Strengths and Limitations
Strengths of this study include its innovative approach to examining presentations of COVID-19 in a
large multicenter cohort, along with identifying major predisposing risk factors and outcomes
associated with delirium. The rigorous medical record extraction process across a large cohort
involving multiple sites in different states has allowed us to confirm clinical observations from smaller
case series. Our study also describes in detail the features and characteristics of prevalent delirium
in this cohort of older ED patients with COVID-19.
Several limitations are important to mention. First, we suspect that the prevalent delirium rate
of 28% observed in this cohort is an underestimate of the true rate, because we were dependent on
medical record documentation where the symptoms are often underreported.37 This was a
necessary limitation because most EDs do not routinely screen for delirium, and clinical research staff
were not allowed in ED settings because of infection control policies during the time of this study.
Moreover, many patients with COVID-19 present to the ED in a critical state, necessitating immediate
intubation, and ED staff may not have had enough time or resources to assess mental status or obtain
collaborative history to confirm a recent change. Less than one-half of our cohort was diagnosed
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using formal delirium assessment tools. Many cases lacked documentation of baseline mental status,
and our approach required a change from baseline to identify delirium. However, we must
acknowledge that delirium may have been misclassified by our record review method. Although the
medical record reviewers could not be blinded to delirium in their reviews, careful training,
standardization, reliability assessments, and adjudication of uncertain ratings were conducted to
enhance accuracy and reliability of medical record delirium diagnoses. Second, to create a
deidentified data set, the investigators were blinded to site by institutional review board
requirements; therefore, we were unable to evaluate any site-specific data. Third, because of the
scarcity of testing in some regions, classic imaging findings were accepted for the diagnosis of
COVID-19 in this study; however, only 4 of these cases were not confirmed by PCR testing. Fourth,
some data, including education, living situation, and socioeconomic status were missing from the
record. Fifth, a large proportion of included patients were from assisted living facilities or nursing
homes (36%) and/or had previously been diagnosed with dementia (30%). Sixth, enrollment
occurred during an 11-week period early in the US pandemic and our study sites were
disproportionately distributed in the Northeastern US, which was undergoing a surge in COVID-19
infections at the time. These factors may limit the generalizability of the findings, especially for
community-dwelling older adults without cognitive impairment, regions not under surge conditions,
and/or during later phases of the pandemic. Seventh, because our study was focused on examining
delirium as a presenting symptom, we did not collect data on incident delirium or on preventable or
precipitating factors occurring during hospitalization. These will be important areas to evaluate in
future research.
Conclusions
Patients with COVID-19 who present with delirium, either as the main symptom or as one of the
presenting symptoms or signs, have worse outcomes, including ICU stay and in-hospital death, than
those without delirium. Our study demonstrates that it is critical to recognize that older adults with
COVID-19 may present with delirium as the primary or sole symptom. In addition, delirium is an
important risk marker to identify patients at high risk for poor outcomes, including death. Future
studies will be critical to evaluate the preventable nature of delirium in COVID-19 and the
effectiveness of tested intervention strategies, such as the Hospital Elder Life Program38 or the
ABCDEF bundle,39 to reduce the severity and duration of delirium and the occurrence of associated
complications. Adding delirium as a common presenting symptom of COVID-19 will keep important
cases from being missed and allow earlier identification and management of vulnerable patients at
high risk for poor outcomes.
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